• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

别嘌醇:史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及其他相关药物反应的发生发展与治疗中的临床考量

Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions.

作者信息

Dillman Kathryn M, Hawkins Alison M, Ragland Amanda R, Wester Grace C, Greene Driskell R, Varrassi Giustino, Moore Peyton, Behara Raju, Ahmadzadeh Shahab, Siddaiah Harish, Shekoohi Sahar, Kaye Alan D

机构信息

Medicine, Louisiana State University Health Sciences Center New Orleans, New Orleans, USA.

Medicine, Louisiana State University Health Sciences Center, Shreveport, USA.

出版信息

Cureus. 2024 Jul 16;16(7):e64654. doi: 10.7759/cureus.64654. eCollection 2024 Jul.

DOI:10.7759/cureus.64654
PMID:39149682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11326749/
Abstract

Allopurinol lowers urate production through the inhibition of xanthine oxidase. It is oxidatively hydroxylated to oxypurinol and is the most prescribed medication for gout treatment. Although it has a beneficial effect in the treatment of this common disease, like many medications, it is also known for having numerous adverse effects. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), diseases that exist on a spectrum, are two of the most dangerous adverse effects associated with allopurinol use. These immune-mediated disease processes involve almost every organ system. They are essential to recognize as early as possible, as they could potentially be deadly, requiring cessation of the medication with initial signs of rash or other early manifestations of SJS/TEN. One major consideration in the increased risk of allopurinol-mediated or modulated SJS/TEN is the need to have a lower dose in the setting of renal disease. The purpose of this review is not only to examine the involvement of allopurinol in SJS/TEN but also to provide detailed information about the drug, allopurinol, and general features and characteristics of SJS/TEN and other associated drug reactions.

摘要

别嘌醇通过抑制黄嘌呤氧化酶降低尿酸生成。它经氧化羟基化生成氧嘌呤醇,是治疗痛风最常用的药物。尽管它对这种常见疾病的治疗有有益作用,但与许多药物一样,它也因有众多不良反应而闻名。史蒂文斯 - 约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)是存在于一个连续谱上的疾病,是与使用别嘌醇相关的两种最危险的不良反应。这些免疫介导的疾病过程几乎涉及每个器官系统。尽早识别它们至关重要,因为它们可能是致命的,一旦出现皮疹的初始迹象或SJS/TEN的其他早期表现,就需要停用该药物。别嘌醇介导或诱发SJS/TEN风险增加的一个主要考虑因素是在肾病情况下需要使用较低剂量。本综述的目的不仅是研究别嘌醇与SJS/TEN的关联,还提供有关药物别嘌醇的详细信息,以及SJS/TEN和其他相关药物反应的一般特征。

相似文献

1
Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions.别嘌醇:史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及其他相关药物反应的发生发展与治疗中的临床考量
Cureus. 2024 Jul 16;16(7):e64654. doi: 10.7759/cureus.64654. eCollection 2024 Jul.
2
Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.在美国,史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症作为降尿酸药物不良事件的风险存在种族差异。
Semin Arthritis Rheum. 2016 Oct;46(2):253-258. doi: 10.1016/j.semarthrit.2016.03.014. Epub 2016 Mar 31.
3
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的最新观点。
Clin Rev Allergy Immunol. 2018 Feb;54(1):147-176. doi: 10.1007/s12016-017-8654-z.
4
Allopurinol-Induced Stevens-Johnson Syndrome (SJS).别嘌醇诱发的史蒂文斯-约翰逊综合征(SJS)。
Clin Pharmacol. 2023 Oct 2;15:99-105. doi: 10.2147/CPAA.S427714. eCollection 2023.
5
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.在欧洲和以色列,别嘌醇是史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症最常见的病因。
J Am Acad Dermatol. 2008 Jan;58(1):25-32. doi: 10.1016/j.jaad.2007.08.036. Epub 2007 Oct 24.
6
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:触发因素分析及对改进预防措施的启示
Am J Med. 2016 Nov;129(11):1221-1225. doi: 10.1016/j.amjmed.2016.03.022. Epub 2016 Apr 15.
7
Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis.人类白细胞抗原变异与别嘌醇诱导的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的关联:一项荟萃分析。
Am J Health Syst Pharm. 2017 May 1;74(9):e183-e192. doi: 10.2146/ajhp160243.
8
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.在泰国人群中,HLA - B*5801与别嘌醇诱发的史蒂文斯 - 约翰逊综合征及中毒性表皮坏死松解症之间存在强关联。
Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.
9
Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.意大利北部史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)的发病率、致病因素及死亡率:来自REACT注册研究的数据
Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):196-203. doi: 10.1002/pds.3937. Epub 2015 Dec 21.
10
Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Signal detection and preventability from Vietnam National pharmacovigilance database.别嘌醇诱发的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症:越南国家药物警戒数据库的信号检测与可预防性
J Clin Pharm Ther. 2022 Dec;47(12):2014-2019. doi: 10.1111/jcpt.13740. Epub 2022 Jul 18.

引用本文的文献

1
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial.在不适合标准治疗的急性痛风患者中,非瑟酮巴尔特与复方倍他米松的对比:一项随机3期试验。
Innovation (Camb). 2025 Jul 5;6(8):101015. doi: 10.1016/j.xinn.2025.101015. eCollection 2025 Aug 4.
2
Real-World pharmacovigilance analysis of drug-related conjunctivitis using the FDA adverse event reporting system database.使用美国食品药品监督管理局不良事件报告系统数据库对药物相关性结膜炎进行的真实世界药物警戒分析。
Sci Rep. 2025 Apr 18;15(1):13407. doi: 10.1038/s41598-025-92796-x.
3
Association between allopurinol and hepatocellular carcinoma: analysis of genetic risk and patient survival.别嘌醇与肝细胞癌之间的关联:遗传风险与患者生存分析
Discov Oncol. 2025 Apr 2;16(1):454. doi: 10.1007/s12672-025-02176-0.
4
An Autobiographical Report of Gout in a Patient Unable to Tolerate Conventional Therapy: The Unbearable Pain of Podagra.一位无法耐受传统疗法的痛风患者的自传报告:足痛风的难忍之痛
Cureus. 2025 Feb 1;17(2):e78343. doi: 10.7759/cureus.78343. eCollection 2025 Feb.
5
Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature review.卡瑞利珠单抗诱导的肺腺癌免疫相关中毒性表皮坏死松解症:一例报告及文献综述
Front Oncol. 2025 Jan 13;14:1417936. doi: 10.3389/fonc.2024.1417936. eCollection 2024.

本文引用的文献

1
Allopurinol-Induced Stevens-Johnson Syndrome (SJS).别嘌醇诱发的史蒂文斯-约翰逊综合征(SJS)。
Clin Pharmacol. 2023 Oct 2;15:99-105. doi: 10.2147/CPAA.S427714. eCollection 2023.
2
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.全球抗生素相关性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的患病率:系统评价和荟萃分析。
JAMA Dermatol. 2023 Apr 1;159(4):384-392. doi: 10.1001/jamadermatol.2022.6378.
3
A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的全身治疗综述
Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.
4
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
5
Clinical Utility of Genotyping to Prevent Allopurinol-Induced SJS/TEN.基因分型在预防别嘌醇诱导的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中的临床应用
Hosp Pharm. 2021 Dec;56(6):660-663. doi: 10.1177/0018578720934972. Epub 2020 Jun 13.
6
Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level.别嘌醇的使用与促甲状腺激素水平升高风险的关联。
Sci Rep. 2021 Oct 13;11(1):20305. doi: 10.1038/s41598-021-98954-1.
7
Toxic Epidermal Necrolysis Caused by Allopurinol: A Serious but Still Underestimated Adverse Reaction.别嘌醇致中毒性表皮坏死松解症:一种严重但仍被低估的不良反应。
Am J Case Rep. 2021 Oct 11;22:e932921. doi: 10.12659/AJCR.932921.
8
Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan.日本近期针对史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的皮肤科治疗方法。
Front Med (Lausanne). 2021 Jul 29;8:636924. doi: 10.3389/fmed.2021.636924. eCollection 2021.
9
Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis.中性粒细胞引发并加剧史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症。
Sci Transl Med. 2021 Jun 30;13(600). doi: 10.1126/scitranslmed.aax2398.
10
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的当前药物遗传学观点
Front Pharmacol. 2021 Apr 26;12:588063. doi: 10.3389/fphar.2021.588063. eCollection 2021.